A Randomized Clinical Trial on Urgent Angioplasty for IntraCranial Atherosclerotic Stenosis-related Large-Vessel Occlusion After Mechanical Thrombectomy

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorChanghai Hospital

About this trial

A prospective, multicenter, randomized controlled, open-label, blinded outcome evaluation (PROBE) trial

Eligibility criteria

Qualifiers

Age ≥ 18 years

National Institutes of Health Stroke Scale (NIHSS) score ≥6 before randomization

To receive mechanical thrombectomy <24 hours after AIS onset according to local guidelines

Signed informed consent form obtained from the subject (or approved surrogate)

Disqualifiers

Pre-stroke mRS >2

Intracranial hemorrhage confirmed by CT before mechanical thrombectomy and enrolment

Suspected Intracranial hemorrhage after successful recanalization confirmed by 3D-CT

Tandem lesions: stenosis (or occlusion) of the extracranial segment of the internal carotid artery or vertebral artery combined with occlusion of large intracranial vessels, stenosis of intracranial arteries combined with occlusion of vessels distal to the stenosis

Trial design

Treatments tested in this trial

  • balloon dilatation and/or stenting
  • medication

Treatment groups

612 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Changhai Hospital

Lead sponsor

The First People's Hospital of Changzhou

Collaborator